Category: Health News

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

In a recent study published in Nature Communications, researchers reported on stromal class I histone deacetylase (HDAC) inhibition to curb pancreatic cancer progression. Study: Inhibiting stromal Class I HDACs curbs pancreatic cancer progression. Image Credit: Tattoboo/ Pancreatic ductal adenocarcinoma (PDAC) is a disease that causes a desmoplastic and treatment-resistant tumor microenvironment (TME), with a predicted

Interactive heatmap reveals England's fattest towns

EXCLUSIVE England’s fattest towns REVEALED… so is YOURS one of them? Use our interactive map to find out Four in 10 people in Kingston upon Hull have a body mass index (BMI) above 40 It means the city in East Yorkshire has the highest obesity rate in the country England’s fattest boroughs are today named

Celebrity Health Routine That You Should Be Following

Celebrities are our benchmark of beauty and health. Their highly publicized lives are our daily source of a break from life, but their lifestyle puts a certain pressure on us normal folks as well. There are many celebrities who look way younger than their age and that is because of the religious health routines they

Scientists unveil 3D structure of key immune system component

Reviewed An international team of researchers from LMU and the Helmholtz Centre for Infection Research has visualized the structure of the so-called ASC speck. A central component of the human immune system, the NLRP3 inflammasome plays an important role in fighting off infections. However, its chronic activation is also implicated in a variety of common

New state-of-the-art genomic services facility opening in the UK

Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024. The GENEWIZ Oxford Genomics Lab. Image Caption: Azenta Life Sciences Drawing upon the experienced team from the former Oxford Genomics

Q&A: Preventing adolescent suicide—recommendations for policymakers, practitioners, and researchers

According to the Centers for Disease Control and Prevention, adolescent suicides have tragically been rising for over a decade and the COVID-19 pandemic’s toll on activities, social connections, and deaths have made these trends increasingly visible. A new Social Policy Report (SPR) from the Steinhardt School of Culture, Education and Human Development at New York

Drug found to extend survival in prostate cancer with genetic mutations

Men with hormone-resistant prostate cancer and specific genetic mutations who were treated with the PARP inhibitor drug olaparib survived longer than men treated with traditional hormone therapy, according to an analysis published in the Journal of Clinical Oncology. Maha Hussain, MD, the Genevieve E. Teuton Professor of Medicine in the Division of Hematology and Oncology

Identification of avoidable risk factors for Parkinson’s Disease

A recent Npj Parkinson's Disease study identified avoidable risk factors for Parkinson’s Disease (PD). Study: Population fraction of Parkinson’s disease attributable to preventable risk factors. Image Credit: meeboonstudio/ Background Based on the current scenario, the most effective way to reduce the global incidence of PD is by eliminating risk factors. Although many studies have estimated the relative risk or

New potential drug suppresses chemotherapy-induced pain

Oncode Investigator Mario van der Stelt and his lab discovered a potential new drug that suppresses chemotherapy-induced neuropathic pain. The results are published in Nature Communications. Neuropathic pain is a common side effect of chemotherapy and one of the major reasons for discontinuation of the treatment. LEI-515 is a substance that stops the breakdown of

Symptoms of white lung pneumonia to look for as illness spreads

China: Families at Beijing hospital amidst pneumonia outbreak In recent weeks countries across the globe have reported new cases of a type of pneumonia that is disproportionately affecting children. Known as mycoplasma pneumonia, the illness first caused concern in China where it is thought there are now thousands of cases. Since then the infection has

Study challenges link between proton pump inhibitors and kidney disease risk

A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney disease (CKD). Study: Proton pump inhibitors and chronic kidney disease risk: A comparative study with histamine-2 receptor antagonists. Image Credit: Iryna Imago / Background PPIs are one